Genetic studies in the sleep disorder narcolepsy

被引:45
作者
Kadotani, H [1 ]
Faraco, J [1 ]
Mignot, E [1 ]
机构
[1] Stanford Univ, Sch Med, Ctr Narcolepsy, Stanford, CA 94305 USA
来源
GENOME RESEARCH | 1998年 / 8卷 / 05期
关键词
D O I
10.1101/gr.8.5.427
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Narcolepsy is a chronic neurologic disorder characterized by excessive daytime sleepiness and abnormal manifestations of REM sleep including cataplexy, sleep paralysis, and hypnagogic hallucinations. Narcolepsy is both a significant medical problem and a unique disease model for the study of sleep. Research in human narcolepsy has led to the identification of specific HLA alleles (DQBI*0602 and DQA1*0102) that predispose to the disorder. This has suggested the possibility that narcolepsy may be an autoimmune disorder, a hypothesis that has not been confirmed to date. Genetic factors other than HLA are also likely to be involved. In a canine model of narcolepsy, the disorder is transmitted as a non-MHC single autosomal recessive trait with full penetrance (canarc-1). A tightly linked marker for canarc-1 has been identified, and positional cloning studies are under way to isolate canarc-1 from a newly developed canine genomic BAC library. The molecular cloning of this gene may lead to a better understanding of sleep mechanisms, as has been the case For circadian rhythms Following the cloning of frq, per, and Clock.
引用
收藏
页码:427 / 434
页数:8
相关论文
共 62 条
[1]   A differential response of two putative mammalian circadian regulators, mper1 and mper2, to light [J].
Albrecht, U ;
Sun, ZS ;
Eichele, G ;
Lee, CC .
CELL, 1997, 91 (07) :1055-1064
[2]  
ALDRICH MS, 1992, NEUROLOGY, V42, P34
[3]   THE NEUROBIOLOGY OF NARCOLEPSY [J].
ALDRICH, MS .
TRENDS IN NEUROSCIENCES, 1991, 14 (06) :235-239
[4]   CANINE MODEL OF NARCOLEPSY - GENETIC AND DEVELOPMENTAL DETERMINANTS [J].
BAKER, TL ;
FOUTZ, AS ;
MCNERNEY, V ;
MITLER, MM ;
DEMENT, WC .
EXPERIMENTAL NEUROLOGY, 1982, 75 (03) :729-742
[5]   Narcolepsy [J].
Bassetti, C ;
Aldrich, MS .
NEUROLOGIC CLINICS, 1996, 14 (03) :545-&
[6]  
BEGOVICH AB, 1992, J IMMUNOL, V148, P249
[7]   HLA-DR2 AND NARCOLEPSY [J].
BILLIARD, M ;
SEIGNALET, J ;
BESSET, A ;
CADILHAC, J .
SLEEP, 1986, 9 (01) :149-152
[8]   LIFE EFFECTS OF NARCOLEPSY IN 180 PATIENTS FROM NORTH-AMERICA, ASIA AND EUROPE COMPARED TO MATCHED CONTROLS [J].
BROUGHTON, R ;
GHANEM, Q ;
HISHIKAWA, Y ;
SUGITA, Y ;
NEVSIMALOVA, S ;
ROTH, B .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1981, 8 (04) :299-304
[9]   EXCESSIVE DAYTIME SLEEPINESS AND THE PATHOPHYSIOLOGY OF NARCOLEPSY-CATAPLEXY - A LABORATORY PERSPECTIVE [J].
BROUGHTON, R ;
VALLEY, V ;
AGUIRRE, M ;
ROBERTS, J ;
SUWALSKI, W ;
DUNHAM, W .
SLEEP, 1986, 9 (01) :205-215
[10]  
Carlander B., 1993, Neurophysiologie Clinique, V23, P15, DOI 10.1016/S0987-7053(05)80279-5